IMS HealthEnglish peopleEnglish musicEnglish footballersEnglish criminal lawEnglish cricket team in Sri Lanka in 2007–08 Clear all search history

IMS Health articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2012/05/25 14:06
2012/05/25 14:06
1d
Medtronic Hypertension Burning Seen as Spurring I...
... led by Novartis AG’s Diovan, which totaled $13.9 billion globally in 2011, according to IMS Health, a Norwalk, Connecticut-based health-care information and services company. More than 42...
Medtronic Inc. Minneapolis George Bakris Melbourne Ian Swanson
MENTIONED
2012/05/25 14:06
2012/05/25 14:06
Latest videos
2012/05/25 14:06
2012/05/25 14:06
Latest from Twitter
2012/05/25 05:08
2012/05/25 05:08
2d
Auxilium, FCB I file suit against Watson over gen...
... any other exclusivities. For the twelve months ending March 31, 2012, Testim® had total U.S. sales of approximately $260 million according to IMS Health data. SOURCE Watson Pharmaceuticals,...
1
RELATED
Testim testosterone Auxilium Pharmaceuticals Inc. U.S. Food and Drug Administration Watson Pharmaceuticals Inc.
MENTIONED
2012/05/24 09:44
2012/05/24 09:44
3d
Aurobindo Pharma surges 8% on US nod for anti-HIV...
Hyderabad facility soon in the US market, Aurobindo Pharma said in a press release. According to IMS Health data the products have a market size of approximately $125 million for the twelve months...
2
RELATED
nevirapine Aurobindo Pharma United States Food and Drug Administration Hyderabad facility Boehringer Ingelheim Pharmaceutical Inc
MENTIONED
2012/05/22 08:52
2012/05/22 08:52
5d
Auxilium, GSK enter sales deal for testosterone g...
... a deal Monday to try to sell more of Testim, Auxilium’s prescription form of the gel. IMS Health, a health-care information and services company, said that from 2006 through the end of...
1
RELATED
Testim testosterone Adrian Adams Auxilium Pharmaceuticals Auxilium Pharmaceuticals Inc.
MENTIONED
2012/05/21 17:59
2012/05/21 17:59
5d
Dr. Reddy's launches blood thinner drug in U.S.
... Sanofi SA had sales of about $ 6.740 billion during 2012 calendar year in U.S., according to IMS Health. Aurobindo Pharma Aurobindo Pharma, too, on Friday, announced that it had received...
clopidogrel Clopidogrel Tablets Plavix U.S. Food and Drug Administration Dr. Reddy's Laboratories
MENTIONED
2012/05/19 07:09
2012/05/19 07:09
8d
Actavis receives FDA approval for Ropinirole ER T...
US sales of approximately $59.4 million for the 12 months ending December 31, 2011, according to IMS Health. Commenting on the new approval, Doug Boothe, CEO of Actavis in the US, said: "The...
Actavis Group Requip Ropinirole Extended-Release Tablets GlaxoSmithKline FDA
MENTIONED
2012/05/18 23:01
2012/05/18 23:01
8d
U.S. risks losing drug research jobs overseas, to...
... lose $120 billion in sales to generic competition by 2015 in the U.S. and Europe, according to IMS Health Inc. Drugmakers are looking outside the U.S. for growth and savings. "It is getting...
4
RELATED
John Castellani IMS Health Inc. CONGRESS Medicare Christopher-Paul Milne
MENTIONED
2012/05/18 18:45
2012/05/18 18:45
8d
Popular Antibiotic Linked with Rare but Deadly He...
... among top-selling antibiotics. U.S. sales last year totaled $464 million, according to IMS Health, a health care information and services company. Pfizer issued a statement saying it...
97
RELATED
Zithromax amoxicillin Vanderbilt University azithromycin Wayne Ray
MENTIONED
2012/05/18 06:17
2012/05/18 06:17
9d
Dr. Reddy’s Announces the Launch of Clopidogrel T...
... approximately $6.740 billion for the most recent twelve months ending March 2012 according to IMS Health. Dr. Reddy’s Clopidogrel Tablets USP, 75 mg are available in bottle count sizes of 30,...
30
RELATED
Plavix clopidogrel Food and Drug Administration Bristol-Myers Squibb Co. Sanofi SA.
MENTIONED
2012/05/15 07:17
2012/05/15 07:17
12d
Axis Communications Strengthens Its Market Leader...
... line with our own predictions, IMS Research forecasts strong, long term growth for network video products with an average yearly growth of 25 percent in the coming years” Axis Communications...
Ray Mauritsson Axis Communications Axis
MENTIONED
2012/05/14 10:52
2012/05/14 10:52
12d
Soldiers, veterans, PTSD and antipsychotic drugs
... PTSD.” Versions of Seroquel brought AstraZeneca nearly $6 billion in revenue last year. IMS Health, a healthcare information and services company, said that in the 12 months ending in...
Read more at Philly.com, Philly.com
1
RELATED
Seroquel Pentagon Stan White Andrew Shirley White
MENTIONED
2012/05/10 13:33
2012/05/10 13:33
16d
FDA Panel Favors Novel Arthritis Drug From Pfizer
... 11th best-selling drugs in the U.S. last year, with combined sales of $7 billion, according to IMS Health. The drugs are also prescribed for psoriasis and other diseases of the immune system....
25
RELATED
Pfizer Food and Drug Administration Pfizer Inc. U.S. Food and Drug Administration Washington
MENTIONED
2012/05/10 08:31
2012/05/10 08:31
17d
ACE inhibitor risk alert urged
... versions such as enalapril, lisinopril, ramipril and captopril - are available. About 162 million prescriptions were filled last year, according to the health-care information firm IMS Hea...
James R. Roberts U.S. Food and Drug Administration Mercy Fitzgerald Hospital Mercy Fitzgerald Hospital Mercy Philadelphia Hospital
MENTIONED
2012/05/10 05:09
2012/05/10 05:09
17d
Shire, Cosmo and Giuliani International file suit...
... occurs sooner, subject to any other exclusivities. For the twelve months ending March 31, 2012, Lialda® had total U.S. sales of approximately $390 million according to IMS Hea...
Watson Pharmaceuticals Inc. U.S. Food and Drug Administration Lialda Shire Development LLC mesalamine
MENTIONED
2012/05/09 19:53
2012/05/09 19:53
17d
Probe finds collusion between India's drug regula...
... percent of global pharmaceuticals sales by 2015, up from just 12 percent in 2005, according to IMS Health. The dash into new markets has brought with it greater scrutiny from U.S. regulators,...
13
RELATED
Central Drugs Standard Control Organisation Brajesh Pathak Standing Committee on Health and Family Welfare New Delhi Reuters
MENTIONED
2012/05/09 17:31
2012/05/09 17:31
17d
Teva Pharmaceutical 1st-quarter profit climbs 13 ...
... revenue. Teva is the 10th largest global pharmaceutical company, according to drug data firm IMS Health. Last fall, it completed its $6.8 billion acquisition of the U.S. drugmaker Cephalon,...
28
RELATED
Wendy's Co. DUBLIN Steve Hare Emil Brolick Jurlique International
MENTIONED
2012/05/07 16:35
2012/05/07 16:35
19d
Fighting cancer, one immune system at a time
... could gain a significant share of the global market for oncology drugs, estimated by IMS Health to reach $75 billion by 2015. Scores of new immunotherapy vaccines and other immune...
6
RELATED
Glenn Dranoff NEW YORK William Coley Dendreon Wolchok
MENTIONED
2012/05/04 09:02
2012/05/04 09:02
23d
Prescription rate for opioids at troubling all-ti...
... $8.5 billion last year, compared with $4.4 billion in 2001, according to the consulting firm IMS Health. Dr. Russell K. Portenoy, who championed the drugs’ broader use, said the new data about...
Oxycontin Christine Link Jane C. Ballantyne Russell K. Portenoy Trescott
MENTIONED
2012/05/01 14:52
2012/05/01 14:52
25d
ACE inhibitor blood-pressure drugs can have a sev...
... million prescriptions were filled last year, according to the health-care information firm IMS Health. But even wonder drugs are not perfect. Soon after the first ACE inhibitor was marketed...
James R. Roberts U.S. Food and Drug Administration Mercy Fitzgerald Hospital Mercy Fitzgerald Hospital Mercy Philadelphia Hospital
MENTIONED
2012/04/30 12:40
2012/04/30 12:40
26d
Mylan Announces Settlement Agreement for its Firs...
... total U.S. sales of $296 million for the 12 months ending Dec. 31, 2011, according to IMS Health. Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in...
3
RELATED
Mylan Inc. Nuvigil Teva Pharmaceutical Industries Ltd. Armodafinil Tablets Teva
MENTIONED
Parts of this website powered by Open Calais, a toolkit for rich semantic metadata extraction.

Huh, what is this?
Interceder is a topic search engine aggregating the latest news on any topic into a single window of information. This page has been automatically generated. To contact Interceder click here.

Privacy Statement
Your privacy is important. Interceder does not collect and keep any personal information about visitors to the site. Interceder may use third-party advertising companies to serve ads. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements on this website, other websites, and other forms of media about goods and services of interest to you.